Coates L, Gladman D, Nash P, FitzGerald O, Kavanaugh A, Rasouliyan L, Pricop L, Ding K, Gaillez C. Secukinumab Achievement of Psoriatic Arthritis Disease Activity Score (PASDAS)-Related Remission: 2-Year Results from a Phase 3 Study. J of Skin [Internet]. 2018Feb.23 [cited 2024Jul.22];2(S1):S17. Available from: https://jofskin.org/index.php/skin/article/view/292